Related Experiment Video

Updated: Jul 7, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

13.7K

Exploring emerging drug responses in Cryptococcus

Wei Liu1, Yiru Gao2, Chen Ding1

  • 1School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China; College of Life and Health Sciences, Northeastern University, Shenyang, China.

Trends in Microbiology
|July 20, 2024
PubMed

Insights

Emerging drug resistance in Cryptococcus poses a significant public health challenge. Understanding these drug responses is crucial for developing more effective anticryptococcal treatments.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Cryptococcosis is a serious global health threat, particularly for immunocompromised individuals.
  • The emergence of drug resistance in Cryptococcus species complicates treatment strategies.
  • Current therapeutic options face limitations due to evolving resistance mechanisms.

Purpose of the Study:

  • To review and discuss the emerging drug responses of Cryptococcus.
  • To highlight the importance of understanding these resistance mechanisms.
  • To inform the development of improved anticryptococcal therapies.

Main Methods:

  • Literature review of recent studies on Cryptococcus drug resistance.
  • Analysis of documented cases and experimental findings related to therapeutic failures.
  • Synthesis of current knowledge on molecular and clinical aspects of resistance.

Main Results:

  • Cryptococcus exhibits resistance to multiple antifungal agents through various mechanisms.
  • Understanding resistance pathways is key to predicting treatment outcomes.
  • Emerging resistance necessitates a re-evaluation of existing and novel therapeutic approaches.

Conclusions:

  • Addressing emerging drug responses in Cryptococcus is critical for public health.
  • Further research into resistance mechanisms will guide the development of next-generation anticryptococcal drugs.
  • Enhanced therapeutic strategies are needed to combat drug-resistant cryptococcosis.
Keywords:
CryptococcusPTMsRNAidrug resistancepersistencetolerance

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.9K
Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research09:06

Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research

Published on: March 29, 2024

706

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...